30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Edward Pesicka

Track

Insider profile

Currently holds a position at Accendra Health Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Accendra Health Inc March 4, 2019 -
Senior Vice President, Chief Commercial Officer Thermo Fisher Scientific Inc Jan. 1, 2014 - March 31, 2015
Senior Vice President, President - Customer Channels Thermo Fisher Scientific Inc July 10, 2008 - Jan. 1, 2014
Edward Pesicka's trades of Accendra Health Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-20 2023-06-16
PlS Planned sale
88,104 +27.9%
469.65
US$3,189,425 		88,104 +27.9% 469.65 US$3,189,425
2023-06-20 2023-06-16
PlS Planned sale
11,719 +2.5%
86.46
US$4,164,117 		11,719 +2.5% 86.46 US$4,164,117
2023-06-20 2023-06-16
PlS Planned sale
68,207 -23.0%
323.23
US$965,263 		68,207 -23.0% 323.23 US$965,263
2023-06-16 2023-06-16
PrS Proposed sale
38,780
19.32
US$749,230 		38,780 19.32 US$749,230
2023-06-20 2023-06-15
PlS Planned sale
5,455 -0.7%
19.23
US$104,903 		5,455 -0.7% 19.23 US$104,903
2023-06-20 2023-06-15
PlS Planned sale
5,837 -0.8%
19.24
US$112,281 		5,837 -0.8% 19.24 US$112,281
2023-06-20 2023-06-15
PlS Planned sale
27,488 -3.5%
19.24
US$528,913 		27,488 -3.5% 19.24 US$528,913
2023-06-15 2023-06-15
PrS Proposed sale
38,780
18.79
US$728,676 		38,780 18.79 US$728,676
2023-06-12 2023-06-09
PlS Planned sale
118,928 -13.1%
20.79
US$2,472,941 		118,928 -13.1% 20.79 US$2,472,941
2023-06-09 2023-06-09
PrS Proposed sale
118,928
21.23
US$2,524,841 		118,928 21.23 US$2,524,841
2023-06-12 2023-06-08
PlS Planned sale
118,928 -11.6%
21.19
US$2,520,120 		118,928 -11.6% 21.19 US$2,520,120
2023-06-08 2023-06-08
PrS Proposed sale
118,928
21.52
US$2,559,331 		118,928 21.52 US$2,559,331
2023-06-08 2023-06-07
PlS Planned sale
118,927 -10.4%
21.56
US$2,564,554 		118,927 -10.4% 21.56 US$2,564,554
2023-06-07 2023-06-07
PrS Proposed sale
118,927
20.77
US$2,470,114 		118,927 20.77 US$2,470,114
2023-06-08 2023-06-06
PlS Planned sale
118,927 -9.4%
20.86
US$2,480,544 		118,927 -9.4% 20.86 US$2,480,544
2023-06-06 2023-06-06
PrS Proposed sale
118,927
21.11
US$2,510,549 		118,927 21.11 US$2,510,549
2022-05-18 2022-05-17
PlS Planned sale
12,028 -0.9%
35.92
US$432,094 		12,028 -0.9% 35.92 US$432,094
2022-05-17 2022-05-16
PlS Planned sale
1,100 -0.1%
36.03
US$39,632 		1,100 -0.1% 36.03 US$39,632
2022-05-17 2022-05-16
PlS Planned sale
53,875 -4.0%
35.31
US$1,902,111 		53,875 -4.0% 35.31 US$1,902,111
2022-05-17 2022-05-16
PlS Planned sale
1,914 -0.1%
36.05
US$69,004 		1,914 -0.1% 36.05 US$69,004
2022-05-17 2022-05-16
PlS Planned sale
75,675 -5.3%
35.30
US$2,671,555 		75,675 -5.3% 35.30 US$2,671,555
2021-11-04 2021-11-03
PlS Planned sale
29,315 -2.3%
42.46
US$1,244,656 		29,315 -2.3% 42.46 US$1,244,656
2021-11-04 2021-11-03
PlS Planned sale
23,728 -1.8%
41.63
US$987,702 		23,728 -1.8% 41.63 US$987,702
2021-11-04 2021-11-03
PlS Planned sale
3,598 -0.3%
40.31
US$145,035 		3,598 -0.3% 40.31 US$145,035